Evaluating AVID, CASH, CIDS, CABG-patch and MADIT: Are they concordant?

Journal of Interventional Cardiac Electrophysiology

Volumn 4, Issue SUPPL. 1, 2000, Pages 103-108

  Böcker, Dirk ^a   Breithardt, Günter ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Implantable cardioverter defibrillator; Trials

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; METOPROLOL;

CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATION; HEART ARRHYTHMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SECONDARY PREVENTION; SUDDEN DEATH;

AGED; ANTI-ARRHYTHMIA AGENTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EVALUATION STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 0034009770     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik S, Fischell RE, Weisfeldt M. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-324.
2. Block M, Breithardt G. Long-term follow-up and clinical results of implantable cardioverter-defibrillators. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: W.B. Saunders Company, 1995:1412-1425.
3. Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol 1990;16: 381-386.
4. Mirowski M, Reid PR, Winkle RA, Mower MM, Watkins L, Stinson EB, Griffith LSC, Kallman CH, Weisfeldt ML. Mortality in patients with implanted automatic defibrillators. Ann Intern Med 1983;98:585-588.
5. Furman S. AICD benefit. Pacing Clin Electrophysiol 1989; 12:399-400.
6. Kim SG, Fisher JD, Furman S, Choue CW, Gross J, Zilo P, Roth JA, Ferrick KJ, Brodman R. Are the benefits of implantable cardioverter/defibrillators overestimated? Cardiol Board Rev 1992;9:76-82.
7. Fogoros RN. The implantable defibrillator backlash. Am J Cardiol 1991;67:1424-1427.
8. Böcker D, Block M, Isbruch F, Wietholt D, Hammel D, Borggrefe M, Breithardt G. Do patients with an implantable defibrillator live longer? J Am Coll Cardiol 1993;21: 1638-1644.
9. Powell AC, Fuchs T, Finkelstein DM, Garan H, Cannom DS, McGovern BA, Kelly E, Vlahakes GJ, Torchiana DF, Ruskin JN. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993;88:1083-1092.
10. Newman D, Sauve MJ, Herre J, Langberg JJ, Lee MA, Titus C, Franklin J, Scheinman MM, Griffin JC. Survival after implantation of the cardioverter defibrillator. Am J Cardiol 1992;69:899-903.
11. Böcker D, Haverkamp W, Block M, Hammel D, Borggrefe M, Breithardt G. Comparison of d,l-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease. Circulation 1996;94:151-157.
12. Wever EF, Hauer RNW, Van Capelle FJL, Tijssen JGP, Crijns HJGM, Algra A, Wiesfeld ACP, Bakker PFA, Rubles de Medina EO. Randomized study of implantable defibrillator as first-choice therapy versus conventional postinfarct sudden death survivors. Circulation 1995;91:2195-2203.
13. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Le vine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, MADIT Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
14. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
15. Kuck KH. ACC NewsOnline: CASH. 1998.
16. Connolly SJ. ACC NewsOnline: CIDS. 1998.
17. Bigger JT Jr, Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 1997;337:1569-1575.
18. Anderson JL, Hallstrom AP, Epstein AE, Pinski SL, Rosenberg Y, Nora MO, Chilson DA, Cannom DS, Moore R, The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. Circulation 1999;99:1692-1699.
19. Siebels J, Cappato R, Ruppel R, Schneider MAE, Kuck KH, the CASH Investigators. Preliminary results of the Cardiac Arrest Study Hamburg (CASH). Am J Cardiol 1993;72: 109F-113F.
20. Moss AJ, Akiyama T, Cannom DS, Fogoros RN, Gallagher J, Griffin JC, Guarnieri T, Hall WJ, Horowitz L, Klein H, Lehmann MH, Levine JH, Maloney JD, Marcus FI, McAnulty JH, Myerburg R, Platia E, Pratt C, Quatromani A, et al. Multicenter automatic defibrillator implantation trial (MADIT): Design and clinical protocol. Pacing Clin Electrophysiol 1991;14:920-927.
21. Buxton AE. MUSTT. Multicenter Unsustained Tachycardia Trial. ACC News Online 1999.
22. Cannom DS, Kay GL, Bhandari AK, Jones MJ, Firth B, Winkle RA, Gaudiani V, Buch W, Fujii J, Singer I, Slater AD, Kupersmith J, Austin EHIII, Pollock S, Stavens CS, Springer MJ, Szabo TS, Adams L, Bigger JT Jr, et al. The Coronary Artery Bypass Graft (CABG) Patch Trial. Prog Cardiovasc Dis 1993;36:97-114.
23. Curtis AB, Cannom DS, Bigger JT Jr, DiMarco JP, Estes NA, Steinman RC, Parides MK. Baseline characteristics of patients in the coronary artery bypass graft (CABG) Patch Trial. Am Heart J 1997;134:787-798.
24. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994;344:493-498.
25. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995;333:77-82.
26. Cairns JA, Connolly SJ, Roberts R, Gent M, the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349: 675-682.
27. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P, the European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-674.
28. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417-1424.
29. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TBJ, Freedman RA, Hlatky MA, Naccarelli GV, Saksena S, Schlant RC, Silka MJ, Ritchie JL, Gibbons RJ, Eagle KA, Gardner TJ, Lewis RP, O'Rourke RA, Ryan TJ, Garson AJ. ACC/AH A guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998;31:1175-1209.
30. Sarter BH, Finkle JK, Gerszten RE, Buxton AE. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? J Am Coll Cardiol 1996;28: 122-129.
31. Kuck KH. Prospective studies assessing prophylactic therapy in high risk patients: The German Dilated CardioMyopathy Study (GDCMS) - Study design. Pacing Clin Electrophysiol 1992;15:697-700.
32. Kuck KH, CAT-Investigators. Ein-Jahres-Mortalität bei Patienten mit dilatativer Kardiomyopathic und implantiertem Kardioverter/Defibrillator: CAT, eine randomisierte, kontrollierte klinische Studie. Zeitschrift für Kardiologie 1998;87[Suppl 1], 207.
33. Nisam S, Mower M. ICD trials: An extraordinary means of determining patient risk? Pacing Clin Electrophysiol 1998; 21:1341-1346.